Evidence map›Paper›PMID 22734955›Full record

ArticleExpert review of anti-infective therapy2012

Cryptococcus gattii as an important fungal pathogen of western North America.

Kieren A Marr

Open access · greenAbstract read
In one paragraph

Article in Expert review of anti-infective therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. American journal of ophthalmology case reports · 2022
    Article
  4. Article
  5. Ophthalmic manifestations ofInternational journal of ophthalmology · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Cryptococcus gattii infections.Clinical microbiology reviews · 2014
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kieren A MarrDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, 720 Rutland Avenue Ross 1064, Baltimore, MD 21205, USA. kmarr4@jhmi.edu
Johns Hopkins University · US

Funding

Patient Oriented Research in Transplant and Oncology IDK24AI085118 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARR, KIEREN A. · 2010 to 2014
$995k
NIAID NIH HHS K24 AI085118
6 · The paper itself

Abstract

Cryptococcus gattii, a pathogenic fungus historically appreciated to be endemic to tropical regions, was recognized to emerge in a more temperate zone of North America in the 1990s. Early reports focused on an outbreak that was first apparent on Vancouver Island (BC, Canada), involving both the veterinary and human population. More recently, it has been recognized that this organism is endemic to a wider geography in western North America, with recognized disease caused by unique molecular subtypes in both healthy and immunosuppressed human hosts and a variety of domestic and wild animals. A number of cases of disease caused by C. gattii isolates that are unrelated to the Vancouver Island-Pacific Northwest outbreak strains have also been recognized in different parts of the USA. As microbiology laboratories have historically not identified these organisms to the species level, our current understanding of the scope of this infection is probably an underestimate. Ongoing public health epidemiologic efforts will be facilitated by increased attention towards culture-confirmed diagnosis and species identification in clinical microbiology laboratories. Early experience presents a strong rationale for increasing diagnostic attention, with multiple clinical features that are unique to this infection, including variability in antifungal susceptibilities and a heightened need for aggressive management of inflammatory responses. Larger prospective studies to evaluate and optimize clinical management are needed.

Indexed as

CryptococcosisAdultAnimalsAntifungal AgentsAzolesCentral Nervous System Fungal InfectionsCryptococcus gattiiFemaleHumansLung Diseases, FungalNorth AmericaAntifungal AgentsAzoles

Identifiers

PMID22734955
PMCPMC3500029
OpenAlexW2125195963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.